UBS Group set a €25.00 ($29.07) price objective on Vivendi (EPA:VIV) in a research report report published on Friday morning, www.boersen-zeitung.de reports. The brokerage currently has a buy rating on the stock.

VIV has been the topic of a number of other reports. Societe Generale set a €26.20 ($30.47) price target on shares of Vivendi and gave the stock a buy rating in a research report on Friday. Deutsche Bank set a €30.00 ($34.88) price target on shares of Vivendi and gave the stock a buy rating in a research report on Friday. Cfra set a €23.00 ($26.74) price target on shares of Vivendi and gave the stock a neutral rating in a research report on Friday. Credit Suisse Group set a €24.50 ($28.49) price target on shares of Vivendi and gave the stock a buy rating in a research report on Friday. Finally, Goldman Sachs Group set a €30.00 ($34.88) price target on shares of Vivendi and gave the stock a buy rating in a research report on Monday, September 17th. Five investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. The company presently has an average rating of Buy and a consensus target price of €25.56 ($29.72).

VIV stock opened at €21.72 ($25.26) on Friday. Vivendi has a 52 week low of €16.85 ($19.59) and a 52 week high of €24.87 ($28.92).

About Vivendi

Vivendi SA operates as a content media and communication company in France, rest of Europe, the United States, and internationally. It operates through Universal Music Group, Canal+ Group, Havas, Gameloft, Vivendi Village, and New Initiatives segments. The Universal Music Group segment is involved in the sale of digital and physical recorded music; and exploitation of music publishing rights, as well as provides artist and merchandising services.

Recommended Story: Risk Tolerance

Analyst Recommendations for Vivendi (EPA:VIV)

Receive News & Ratings for Vivendi Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vivendi and related companies with MarketBeat.com's FREE daily email newsletter.